← All trials
NCT03721679
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 25, 2018
- Primary completion
- Aug 31, 2020
- Completion date
- Aug 31, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 60
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Oncovir, Inc.Lead sponsor
- Icahn School of Medicine at Mount SinaiCollaborator
- Icahn School of Medicine at Mount SinaiOverall official - principal investigator
- Bay Hematology OncologyCollaborator
- Bay Hematology OncologyOverall official - principal investigator
- Chevy Chase Healthcare, Chevy Chase MDCollaborator
- Chevy Chase Healthcare, Chevy Chase MDOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.